Recent Material Events - Novavax, Inc (NVAX)

Filing Date	Description
2008-08-08	On August 8, 2008, Novavax, Inc. (the “Company”) issued a press release announcing its financial results for the second quarter ended June 30, 2008 and will conduct a previously announced, publicly available conference call to discuss those ...
2008-07-30	On July 28, 2008, Novavax, Inc. (the “Company”) entered into agreements for the sale of units (the “Units”), with each Unit consisting of (i) one share of the Company’s common stock, par value $0.01 per share (“Common St ...
2008-07-03	On June 26, 2008, Novavax, Inc. (“Novavax”) amended the lease for its corporate headquarters at 9920 Belward Campus Drive in Rockville, Maryland. The amendment (1) extends the term of the lease to January 31, 2017, (2) provides that the lan ...
2008-05-09	On May 9, 2008, Novavax, Inc. (the “Company”) issued a press release announcing its financial results for the first quarter ended March 31, 2008 and will conduct a previously announced, publicly available conference call to discuss those re ...
2008-03-14	On March 14, 2008, Novavax, Inc. (the “Company”) issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2007 and will conduct a previously announced, publicly available conference call to ...
2008-02-08	On February 4, 2008, Rick A. Bright’s employment with Novavax, Inc. (the “Company”) as the Vice President of Global Influenza Programs ended. The Company has offered Dr. Bright an agreement (the “Agreement”), which provides t ...
2008-01-31	On January 31, 2008, Novavax, Inc. (the “Company”) posted a letter to its stockholders to its website that describes the Company’s 2007 achievements and goals for 2008. The letter contains statements that are “forward-looking stat ...
2007-12-20	On December 20, 2007, Novavax, Inc. (the “Company”) announced interim results from a Phase I/IIa human clinical trial of its pandemic influenza virus-like particle (VLP) vaccine candidate and will conduct a publicly available conference cal ...
2007-12-10	On December 10, 2007, Novavax, Inc. (the “Company”) announced that it has entered into a collaboration agreement with GE Healthcare, a unit of General Electric Company, to develop and co-market a pandemic influenza vaccine manufacturing sol ...
2007-11-09	On November 12, 2007, Novavax, Inc. (the “Company”) will issue a press release announcing its financial results for the third quarter ended September 30, 2007 and will conduct a previously announced, publicly available conference call to di ...